Encouraging Abstinence Behavior in a Drug Epidemic: Optimizing Dynamic Incentives

Launched by WAKE FOREST UNIVERSITY HEALTH SCIENCES · Jun 9, 2021

Keywords

ClinConnect Summary

This clinical trial, titled "Encouraging Abstinence Behavior in a Drug Epidemic," is studying how financial incentives can help people struggling with opioid or cocaine use disorders to stay sober. The trial will test two different ways of giving these incentives through a mobile app that participants can easily use. One method will increase the rewards for staying clean, while the other will decrease them based on success. The goal is to find out which approach works better in encouraging people to avoid drugs and improve their health.

To participate, you must be at least 18 years old and currently receiving treatment for substance use disorders, such as opioids, cocaine, or methamphetamines. You’ll need access to a smartphone and be comfortable using an app. Participants will be monitored for their success in staying drug-free, and they can expect to receive support through this innovative program. The trial aims to learn more about effective ways to help individuals overcome addiction and improve their chances of recovery.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age at least 18 years old;
• • Meet DSM-5 OUD, CoUD, or MUD criteria as evidenced by an OUD CPT code F11\* (opioid related disorders), a CoUD CPT code F14\* (cocaine related disorders), a MUD CPT code F15.1/F15.2 or other clinical notes indicating illicit opioid/cocaine/methamphetamine use for treatment
• • Have access to a smartphone (iOS or Android) with data plan and willing to download DynamiCare app;
• • Have an email and can access it from their smartphone;
• • Are in residential, day (PHP), partial day (IOP), or outpatient (OP) AODA treatment;
• * Are likely to be helped by contingency management because at least ONE of the following conditions is true:
• • 1. Were first enrolled in residential, PHP, or IOP substance use treatment no longer than 2 treatment weeks (14 days/encounters of treatment) prior to providing informed consent.
• • 2. Used non-medical opioids, cocaine, and/or methamphetamine within the last 21 days.
• • Understands English.
• Exclusion Criteria:
• • Have evidence of active (non-substance related) psychosis that might impair participation as determined by the PI.
• • Has significant cognitive impairment that might confound participation as determined by the PI or are so significantly cognitively impaired that they have a legal guardian.